questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Vessie neurologique
Vessie neurologique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Drug Administration Schedule
Diagnostic
5
Vessie neurologique
Urodynamique
Cystométrie
Électromyographie
Incontinence urinaire
Rétention urinaire
Imagerie par résonance magnétique
Lésions neurologiques
Symptômes
5
Incontinence urinaire
Douleurs pelviennes
Douleurs abdominales
Dysfonction vésicale
Personnes âgées
Comorbidités
Prévention
5
Prévention
Maladies neurologiques
Mode de vie sain
Hydratation
Éducation des patients
Complications
Suivi médical
Aggravations
Exercices du plancher pelvien
Contrôle vésical
Traitements
5
Médicaments
Thérapies comportementales
Anticholinergiques
Bêta-3 agonistes
Intervention chirurgicale
Traitements conservateurs
Rééducation vésicale
Entraînement à la miction
Cathéters
Dispositifs médicaux
Complications
5
Infections urinaires
Lésions rénales
Infections urinaires
Auto-cathétérisme
Lésions rénales
Vessie neurologique
Facteurs de risque
5
Lésions médullaires
Maladies neurologiques
Âge
Troubles neurologiques
Antécédents médicaux
Accidents vasculaires cérébraux
Sexe
Conditions neurologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vessie neurologique : Questions médicales les plus fréquentes",
"headline": "Vessie neurologique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vessie neurologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-21",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vessie neurologique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Manifestations neurologiques",
"url": "https://questionsmedicales.fr/mesh/D009461",
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neurologiques",
"code": {
"@type": "MedicalCode",
"code": "D009461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vessie neurologique",
"alternateName": "Urinary Bladder, Neurogenic",
"code": {
"@type": "MedicalCode",
"code": "D001750",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Margaret A Fitzpatrick",
"url": "https://questionsmedicales.fr/author/Margaret%20A%20Fitzpatrick",
"affiliation": {
"@type": "Organization",
"name": "Center of Innovation for Veteran-Centered and Value-Driven Care, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America."
}
},
{
"@type": "Person",
"name": "Marissa Wirth",
"url": "https://questionsmedicales.fr/author/Marissa%20Wirth",
"affiliation": {
"@type": "Organization",
"name": "Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, United States of America."
}
},
{
"@type": "Person",
"name": "Frances M Weaver",
"url": "https://questionsmedicales.fr/author/Frances%20M%20Weaver",
"affiliation": {
"@type": "Organization",
"name": "Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, United States of America."
}
},
{
"@type": "Person",
"name": "Katie J Suda",
"url": "https://questionsmedicales.fr/author/Katie%20J%20Suda",
"affiliation": {
"@type": "Organization",
"name": "Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, United States of America."
}
},
{
"@type": "Person",
"name": "Nasia Safdar",
"url": "https://questionsmedicales.fr/author/Nasia%20Safdar",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Division of Infectious Diseases, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Online scheduling using a fixed template: the case of outpatient chemotherapy drug administration.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36319888",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10729-022-09616-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elotuzumab: Empiric analysis of dexamethasone administration schedule.",
"datePublished": "2023-10-25",
"url": "https://questionsmedicales.fr/article/37876226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10781552231207855"
}
},
{
"@type": "ScholarlyArticle",
"name": "NASN's Medication Administration Clinical Guideline.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35567332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/1942602X221098735"
}
},
{
"@type": "ScholarlyArticle",
"name": "Strategies for cessation of caffeine administration in preterm infants.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39045901",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD015802.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer.",
"datePublished": "2022-08-09",
"url": "https://questionsmedicales.fr/article/35943644",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10147-022-02226-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vessie neurologique",
"item": "https://questionsmedicales.fr/mesh/D001750"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vessie neurologique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vessie neurologique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vessie neurologique",
"description": "Comment diagnostiquer une vessie neurologique ?\nQuels tests sont utilisés pour évaluer la fonction vésicale ?\nQuels signes cliniques indiquent une vessie neurologique ?\nQuel rôle joue l'imagerie dans le diagnostic ?\nComment évaluer la gravité de la condition ?",
"url": "https://questionsmedicales.fr/mesh/D001750?mesh_terms=Drug+Administration+Schedule#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vessie neurologique",
"description": "Quels sont les symptômes courants de la vessie neurologique ?\nLa vessie neurologique cause-t-elle des douleurs ?\nComment la vessie neurologique affecte-t-elle la miction ?\nY a-t-il des symptômes psychologiques associés ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D001750?mesh_terms=Drug+Administration+Schedule#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vessie neurologique",
"description": "Peut-on prévenir la vessie neurologique ?\nQuels conseils de mode de vie peuvent aider ?\nL'éducation des patients est-elle importante ?\nComment le suivi médical contribue-t-il à la prévention ?\nLes exercices du plancher pelvien sont-ils bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D001750?mesh_terms=Drug+Administration+Schedule#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vessie neurologique",
"description": "Quels traitements sont disponibles pour la vessie neurologique ?\nLes médicaments sont-ils efficaces ?\nQuand envisager une intervention chirurgicale ?\nQuelles thérapies comportementales sont recommandées ?\nY a-t-il des dispositifs médicaux utiles ?",
"url": "https://questionsmedicales.fr/mesh/D001750?mesh_terms=Drug+Administration+Schedule#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vessie neurologique",
"description": "Quelles complications peuvent survenir ?\nComment les infections urinaires sont-elles liées ?\nLes lésions rénales sont-elles une préoccupation ?\nQuels troubles psychologiques peuvent survenir ?\nComment éviter les complications ?",
"url": "https://questionsmedicales.fr/mesh/D001750?mesh_terms=Drug+Administration+Schedule#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vessie neurologique",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque de vessie neurologique ?\nLes habitudes de vie peuvent-elles augmenter le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001750?mesh_terms=Drug+Administration+Schedule#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vessie neurologique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'anamnèse, l'examen clinique et des tests urodynamiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la fonction vésicale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, la cystométrie et l'électromyographie."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une vessie neurologique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent incontinence, rétention urinaire et mictions fréquentes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie, comme l'IRM, aide à identifier les lésions neurologiques sous-jacentes."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité de la condition ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par la fréquence des symptômes et l'impact sur la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la vessie neurologique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent incontinence, urgences urinaires et douleurs pelviennes."
}
},
{
"@type": "Question",
"name": "La vessie neurologique cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs pelviennes ou abdominales peuvent survenir en raison de la dysfonction."
}
},
{
"@type": "Question",
"name": "Comment la vessie neurologique affecte-t-elle la miction ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des mictions fréquentes, des fuites ou une incapacité à uriner."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent survenir en raison des problèmes urinaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de comorbidités."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vessie neurologique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention dépend de la gestion des maladies neurologiques sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quels conseils de mode de vie peuvent aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant l'exercice et une bonne hydratation, peut aider."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation aide les patients à mieux gérer leurs symptômes et à éviter les complications."
}
},
{
"@type": "Question",
"name": "Comment le suivi médical contribue-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier permet d'ajuster les traitements et de prévenir les aggravations."
}
},
{
"@type": "Question",
"name": "Les exercices du plancher pelvien sont-ils bénéfiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils renforcent les muscles pelviens et peuvent améliorer le contrôle vésical."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vessie neurologique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des thérapies comportementales et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticholinergiques et des bêta-3 agonistes peuvent réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si les traitements conservateurs échouent à contrôler les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles thérapies comportementales sont recommandées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies incluent la rééducation vésicale et l'entraînement à la miction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des dispositifs médicaux utiles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dispositifs comme les cathéters intermittents peuvent aider à gérer la condition."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections urinaires, lésions rénales et troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Comment les infections urinaires sont-elles liées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections urinaires sont fréquentes en raison de la rétention urinaire et de l'auto-cathétérisme."
}
},
{
"@type": "Question",
"name": "Les lésions rénales sont-elles une préoccupation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une vessie neurologique non traitée peut entraîner des lésions rénales graves."
}
},
{
"@type": "Question",
"name": "Quels troubles psychologiques peuvent survenir ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété et la dépression sont courantes en raison des défis liés à la gestion des symptômes."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et une bonne hygiène peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent les lésions médullaires, les maladies neurologiques et les infections."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge en raison de la prévalence accrue des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies neurologiques ou d'accidents vasculaires cérébraux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de vessie neurologique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines conditions neurologiques affectent différemment les hommes et les femmes."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles augmenter le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'obésité peuvent contribuer à des problèmes neurologiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/04/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
Center of Innovation for Veteran-Centered and Value-Driven Care, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America.
Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
6 publications dans cette catégorie
Affiliations :
Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, United States of America.
6 publications dans cette catégorie
Affiliations :
Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, United States of America.
Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, IL, United States of America.
6 publications dans cette catégorie
Affiliations :
Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, United States of America.
Department of Medicine, Center for Research on Healthcare, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.
6 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Infectious Diseases, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America.
Department of Medicine, Division of Infectious Diseases, William S. Middleton VA Hospital, Madison, WI, United States of America.
6 publications dans cette catégorie
Affiliations :
College of Nursing, University of Illinois Chicago, Chicago, IL, United States of America.
6 publications dans cette catégorie
Affiliations :
Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, United States of America.
Center for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
5 publications dans cette catégorie
Affiliations :
Spinal Cord Injury/Disorders Service, VA Puget Sound Healthcare System, Seattle, WA, United States of America.
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, United States of America.
Publications dans "Vessie neurologique" :
4 publications dans cette catégorie
Affiliations :
Collaborative for Research on Outcomes and Metrics, Silver Spring, Maryland.
Departments of Neurology, Rehabilitation Medicine, and Biostatistics, Bioinformatics & Biomathematics, Georgetown University, Washington, DC.
Publications dans "Vessie neurologique" :
4 publications dans cette catégorie
Affiliations :
Collaborative for Research on Outcomes and Metrics, Silver Spring, Maryland.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Department of Rehabilitation Medicine, Georgetown University Medical Center, Washington, DC.
MedStar National Rehabilitation Hospital, Washington, DC.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Collaborative for Research on Outcomes and -Metrics, Georgetown University, Washington, DC.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
MedStar National Rehabilitation Hospital, Washington, DC.
MedStar Health Research Institute, Hyattsville, MD.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
MedStar National Rehabilitation Hospital, Washington, DC.
MedStar Health Research Institute, Hyattsville, MD.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, United States of America.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Sorbonne université, hôpital Pitié-Salpêtrière, service d'urologie, assistance publique-hôpitaux de Paris, Paris, France. Electronic address: veronique.phe@aphp.fr.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Département d'urologie, transplantation rénale et andrologie, CHU Rangueil, université Paul-Sabatier, Toulouse, France.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Department of Urology, Norfolk and Norwich University Hospital, Norwich, UK.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Department of Urology, HUP La Fe, Valencia, Spain.
Publications dans "Vessie neurologique" :
3 publications dans cette catégorie
Affiliations :
Department of Urology, Charing Cross Hospital, London, UK.
Publications dans "Vessie neurologique" :
In this paper, we use a fixed template of slots for the online scheduling of appointments. The template is a link between planning the service capacity at a tactical level and online scheduling at an ...
Elotuzumab in combination with dexamethasone and immunomodulating agents (IMiDs) lenalidomide or pomalidomide is 2nd to 4th line therapy for multiple myeloma. The labelled dosage of dexamethasone for ...
Despite the volume of medications that are administered in schools, school nurse guidelines for administering medications in schools lacked the support of empirical literature to guide best practices....
Apnea and intermittent hypoxemia (IH) are common developmental disorders in infants born earlier than 37 weeks' gestation. Caffeine administration has been shown to lower the incidence of these disord...
To evaluate the effects of early versus late discontinuation of caffeine administration in preterm infants....
We searched CENTRAL, PubMed, Embase, and three trial registries in August 2023; we applied no date limits. We checked the references of included studies and related systematic reviews....
We included randomized controlled trials (RCTs) in preterm infants born earlier than 37 weeks' gestation, up to a PMA of 44 weeks and 0 days, who received caffeine for any indication for at least seve...
We used standard Cochrane methods. Primary outcomes were: restarting caffeine therapy, intubation within one week of treatment discontinuation, and the need for non-invasive respiratory support within...
We included three RCTs (392 preterm infants). Discontinuation of caffeine at PMA less than 35 weeks' gestation versus PMA equal to or longer than 35 weeks' gestation This comparison included one singl...
There may be little or no difference in the incidence of all-cause mortality and apnea in infants who were randomized to later discontinuation of caffeine treatment. However, the number of infants wit...
Cetuximab (Cmab) plays an important role in the treatment for recurrent or metastatic head and neck cancer (R/M HNC). To date, however, no safety data on biweekly administration of cetuximab at a dose...
We retrospectively reviewed the clinical records of five R/M HNC patients who received biweekly Cmab in our institute between January 2016 and September 2021 and compared the safety profile between tw...
All patients initially received Cmab in combination with chemotherapy. Chemotherapy consisted of paclitaxel plus carboplatin in two patients, cisplatin + 5-FU in one patient, and paclitaxel in two pat...
Biweekly Cmab was well tolerated and did not demonstrate severe toxicities related to Cmab for R/M HNC....
Tyrosine kinase inhibitors (TKIs) have demonstrated significant efficacy against various types of cancers through molecular targeting mechanisms. Over the past 22 years, more than 100 TKIs have been a...
The standard meropenem (MEPM) regimen allowed by insurance in Japan is 0.5 g two or three times a day. Differences in dosages and administration schedules in Japan were evaluated....
Patients with bacteremia for whom MEPM was used as the initial treatment at our institution between 2016 and 2021 were included. We retrospectively investigated patients classified into two groups: th...
The probability of 100% fT > MIC was significantly higher in the high-dose group (96.4% vs 74.5%, odds ratio [OR] = 0.3, 95% confidence interval [CI] = 0.2-0.4, P = < 0.001). Regarding outcomes, the 3...
To improve outcomes in patients with bacteremia treated with MEPM, support for appropriate antimicrobial use is necessary for compliance with the dosage and administration schedule according to severe...
The growing evidence detailing the harmful effects of exposure to antibiotics has driven an urgency to evaluate recommendations in common pediatric infections regarding antibiotic course duration and ...
The optimal timing of tocilizumab treatment during the disease course of COVID-19 has yet to be adequately defined in the context of randomised controlled trials and the effect of tocilizumab on real-...
All adults (≥18 years old) with confirmed COVID-19 admitted to four hospitals in the West of Scotland between 8 January 2021 and 31 March 2021 and who received tocilizumab were included in a retrospec...
203 patients were included in the analysis (138 in the early cohort, 65 in the late cohort). Mortality in 90 days in the early cohort was 22% (n=30) compared with 45% (n=29) in the late cohort (p<0.00...
Early administration of tocilizumab within the first 2 days of hospitalisation was associated with a significant survival benefit compared with late exposure. Late administration was associated with p...
Hospice and palliative care have been shown to increase patient satisfaction and improve symptom control at the end of life. Opioid analgesics are typically given around the clock at the end of life t...
This was a retrospective, quasi-experimental study at a 766-bed community hospital with hospice and palliative care services. Adult patients admitted to inpatient hospice care with active orders for s...
A total of 75 patients were included in the final analysis. The rate of missed doses was 5% in the pre-implementation cohort and 4% in the post-implementation cohort (...
The creation and dissemination of nursing education were not associated with a decrease in missed or delayed doses of scheduled opioids in hospice patients....